Simon Anderhub - Concepedia

Author

Simon Anderhub

Phenex Pharmaceuticals (Germany)

Also Known As

S Anderhub, Simon Anderhub, Simon J Anderhub, Simon J. Anderhub

Publications

646

Citations

H-Index

Concepts

All Affiliations

Phenex Pharmaceuticals (Germany)Heidelberg University German Cancer Research Center Cancer Research UK Breast Cancer Now

About

Simon Anderhub is an author at Phenex Pharmaceuticals (Germany) specializing in natural sciences, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	78
2	Natural Sciences	3	3	78
3	Biochemistry	1	1	17
4	Biomolecular Engineering	1	1	49
5	Cell Biology	1	1	12

Simon Anderhub

Publications

549

Citations

H-Index

Page 1

	Year	Citations
Proteins Required for Centrosome Clustering in Cancer Cells Blanka Leber, Bettina Maier, Florian Fuchs, Science Translational Medicine	2010	175
GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth <i>In Vitro</i> and <i>In Vivo</i> Marc S. Raab, Iris Breitkreutz, Simon Anderhub, Cancer Research	2012	66
The novel actin/focal adhesion-associated protein MISP is involved in mitotic spindle positioning in human cells Bettina Maier, Michael Kirsch, Simon Anderhub, Cell Cycle	2013	51
Disparate SAR Data of Griseofulvin Analogues for the Dermatophytes Trichophyton mentagrophytes, T. rubrum, and MDA-MB-231 Cancer Cells Mads H. Rønnest, Marc S. Raab, Simon Anderhub, Journal of Medicinal Chemistry Mda-mb-231 Cancer CellsMedicinal ChemistryAntifungal AgentBioorganic ChemistryDisparate Sar Data	2011	49
Gene silencing induced by oxidative DNA base damage: association with local decrease of histone H4 acetylation in the promoter region Andriy Khobta, Simon Anderhub, Nataliya Kitsera, Nucleic Acids Research	2010	47
Aurora B prevents premature removal of spindle assembly checkpoint proteins from the kinetochore: A key role for Aurora B in mitosis Mark D. Gurden, Simon Anderhub, Amir Faisal, Oncotarget	2016	40
High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers Simon Anderhub, Grace Wing-Yan Mak, Mark D. Gurden, Molecular Cancer Therapeutics	2019	37
Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy Amir Faisal, Grace Wing-Yan Mak, Mark D. Gurden, British Journal of Cancer	2017	26
Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation Christoph Steeneck, Olaf Kinzel, Simon Anderhub, ACS Medicinal Chemistry Letters	2020	19
Discovery and optimization of substituted oxalamides as novel heme-displacing IDO1 inhibitors Christoph Steeneck, Olaf Kinzel, Simon Anderhub, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesHeme Degradation	2020	17

Page 1